TITLE

Interactions between physicians and the pharmaceutical industry: what does the literature say?

AUTHOR(S)
Lexchin, Joel; Lexchin, J
PUB. DATE
November 1993
SOURCE
CMAJ: Canadian Medical Association Journal;11/15/1993, Vol. 149 Issue 10, p1401
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
No abstract available.
ACCESSION #
35471065

 

Related Articles

  • Erratum to: Changing Interactions Between Physician Trainees and the Pharmaceutical Industry: A National Survey. Austad, Kirsten; Avorn, Jerry; Franklin, Jessica; Kowal, Mary; Campbell, Eric; Kesselheim, Aaron // JGIM: Journal of General Internal Medicine;Aug2013, Vol. 28 Issue 8, p1115 

    A correction to the article "Changing Interactions Between Physician Trainees and the Pharmaceutical Industry: A National Survey" is presented.

  • The dermatologist, the gift, PhRMA.  // Dermatology Times;Mar2007, Vol. 28 Issue 3, p6 

    The article discusses the relationship between pharmaceutical companies and physicians. Pharmaceutical companies offer incentives to doctors to convince them to prescribe their products. "Code on Interactions with Healthcare Professionals," was issued by the Pharmaceutical Research and...

  • Physician Trainees' Interactions with the Pharmaceutical Industry. Ramachandran, Reshma; Hams, Marcia; Silver-Isenstadt, Jean // JGIM: Journal of General Internal Medicine;Oct2013, Vol. 28 Issue 10, p1266 

    A letter to the editor is presented in response to the article "Changing Interactions Between Physician Trainees and the Pharmaceutical Industry: A National Survey" by K. E. Austad and colleagues.

  • Physician Trainees' Interactions with the Pharmaceutical Industry. Austad, Kirsten; Avorn, Jerry; Franklin, Jessica; Kesselheim, Aaron // JGIM: Journal of General Internal Medicine;Oct2013, Vol. 28 Issue 10, p1267 

    A response from the authors of the article "Changing interactions between physician trainees and the pharmaceutical industry: a national survey" in the February 27, 2013 issue, is presented.

  • The Doctor's World: What not to say to a physician and why. Berliner, Neil // Pharmaceutical Representative;Feb2007, Vol. 37 Issue 2, p32 

    The article discusses the guidelines on why and what pharmaceutical representatives should not say to physicians. A list of restricted statements, along with the proper methods of interacting with doctors, is discussed. The author also discourages creating an argument that heightens only the...

  • Don't Give Up! Cramer, Sharon; Stivers, Jan // Teaching Exceptional Children;Jul/Aug2007, Vol. 39 Issue 6, p6 

    The article presents questions and answers related to collaboration between special education and regular education teachers. INSET: What Does the Literature Say About Teacher Collaboration?.

  • AN AGENCY THEORY PERSPECTIVE ON PHYSICIAN INTERACTIONS WITH THE PHARMACEUTICAL INDUSTRY. YOON, PHILIP W. // Academy of Management Proceedings;2004, pD1 

    The relationship between the pharmaceutical industry and the medical profession is a provocative topic and has been increasingly scrutinized within the medical literature. In this article, I examine the gift-giving practices of pharmaceutical companies and their effects on physician behavior. I...

  • Breaking it Down. Acton, Kevin // Pharmaceutical Representative;Sep2010, Vol. 40 Issue 9, p30 

    The article offers the author's insights of the significance of the tool "Call Profile Worksheet (CPW)" which he has developed to evaluate the physician-representative interaction for pharmaceutical sales representative in pharmaceutical industry in the U.S. He tackles the CPW structure...

  • Changing times indeed. Anderson, Peter // Canadian Urological Association Journal;jan/fev2014, Vol. 8 Issue 1/2, p19 

    The article explores his views on the impact of the sunshine laws on Canadian physicians as it will lead to substantial changes in physician-pharmaceutical industry interaction.

  • Recognizing Conflict of Interest in Orthopaedic Surgery. Montero-Lopez, Nicole M.; Khan, Mani; Niggam, Shikka; Zuckerman, Joseph D.; Egol, Kenneth A. // Bulletin of the Hospital for Joint Diseases;2014, Vol. 72 Issue 4, p271 

    The relationship between pharmaceutical and biomedical technology companies (industry) and medical practitioners has been a topic of discussion and concern for several decades. The large monetary payments and extravagant gifts to physicians from these companies have been regulated and largely...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics